News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Japan Biotech Firm OncoTherapy Science, Inc. Bid Only On Debut


10/19/2005 5:09:26 PM

Shares in biotechnology firm OncoTherapy Science Inc (Tokyo:4564.T - News) remained bid-only on their stock market debut on Monday, benefiting from small investors' appetite for initial public offering issues (IPOs). The issue, the biggest IPO this year in Japan's start-up markets, was untraded due to a glut of bid orders at two million yen ($18,560) -- twice its issue price -- on the Tokyo Stock Exchange's Mothers market.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES